[Mechanism of the protective effect of modifiers of the liver enzyme systems metabolyzing xenobiotics in acute T-2 mycotoxicosis].
D000208:Acute Disease; D000818:Animals; D003035:Cobalt / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004790:Enzyme Induction / Q000187:drug effects; D008658:Inactivation, Metabolic; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008748:Methylcholanthrene / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D012717:Sesquiterpenes / Q000506:poisoning*; D013605:T-2 Toxin / Q000378:metabolism / Q000506:poisoning*
D012717:Sesquiterpenes; D003035:Cobalt; D008748:Methylcholanthrene; C018021:cobaltous chloride; D013605:T-2 Toxin; D010634:Phenobarbital
K mekhanizmu zashchitnogo éffekta nekotorykh modifikatorov fermentnykh sistem pecheni, metaboliziruiushchikh ksenobiotiki, pri ostrom T-2 mikotoksikoze.